Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
FTC sues drug middlemen over manipulating the insulin market
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in exchange for keeping lower-cost insulin off their lists of approved
Cigna Sues Federal Trade Commission Over ‘Defamatory’ Report
Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes pharmacy benefit managers and asked the court to order the agency to retract it.
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
FTC Sues CVS, Cigna, UnitedHealth Over Rising Insulin Costs (1)
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove up the price of insulin.
FTC Sues Drug Middlemen Over Manipulating Insulin Market
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove up the price of insulin.
High Insulin Prices Spur a Federal Lawsuit Against Three Pharmacy Benefit Managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for patients
FTC sues pharmacy insurance managers, alleging unfair drug prices
The FTC accuses the largest pharmacy benefit manager companies of unfairly boosting prices on prescription drugs.
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin prices and steering patients toward higher-cost insulin products to increase their profits.
3d
Cigna: Growth From Specialty Pharmacy And Care; Initiate With 'Buy'
Cigna Healthcare's divestiture of low-margin Medicare businesses will allow focus on employer-sponsored plans. Learn more on ...
1d
Cigna Group stock outperforms competitors despite losses on the day
Cigna Group closed $14.69 short of its 52-week high ($370.83), which the company reached on September 16th.
Fierce Healthcare
2d
Cigna trims Medicare Advantage plans in eight states
Cigna is reshaping its Medicare Advantage (MA) plan lineup across eight states, affecting members in 36 health plans. | Cigna ...
Modern Healthcare
3d
Cigna to cut Medicare Advantage plans in several states
Cigna is joining the chorus of health insurance companies detailing where they will scale back Medicare Advantage offerings ...
Healthcare Dive
2d
Cigna scaling back Medicare Advantage footprint in 8 states next year
The reductions will affect roughly 5,400 members, mostly in Florida, according to a notice to marketing agents.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback